
Kayentis & RWS partnering for success
Kayentis (global provider of eCOA and DCT solutions) and RWS (language service provider (LSP) and
Kayentis & RWS partnering for success
Kayentis (global provider of eCOA and DCT solutions) and RWS (language service provider (LSP) and linguistic validation experts) were selected to create and implement the electronic versions of the COAs (eCOAs) on a high priority study with a new client, pioneer in biotechnology.
The study is a Global Small Cell Lung Cancer Phase II Study, spanning 26 languages and 7 instruments, with 100 participating sites.
The long-standing partnership between Kayentis and RWS enabled a successful study start-up so that the final study materials were completed and delivered earlier than quoted timelines.
The collaborative efforts established between both partners helped mitigate any potential delays arising from external review requirements and changing priorities to ensure a successful study.
Learn more:
Kayentis (global provider of eCOA and DCT solutions) and RWS (language service provider (LSP) and
Provide clinical trial participants with clear and simple information, anywhere, anytime thanks to the Kayentis
Using technology to add flexibility to clinical trials can support patients and sites – but
Many of the challenges of clinical trials are well known, but oncology trials differ from
Patients taking part in clinical trials need clear and simple information – this is what
Clin’form App is the Kayentis BYOD solution, available for patients and caregivers to facilitate decentralized
Last update : 27 July 2022